Application 020364

Type
NDA
Sponsor
NOVARTIS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
002LOTRELAMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDECAPSULE;ORALEQ 2.5MG BASE;10MGYesNo
003LOTRELAMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDECAPSULE;ORALEQ 5MG BASE;10MGYesNo
004LOTRELAMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDECAPSULE;ORALEQ 5MG BASE;20MGYesNo
005LOTRELAMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDECAPSULE;ORALEQ 10MG BASE;20MGYesNo
006LOTRELAMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDECAPSULE;ORALEQ 10MG BASE;40MGYesYes
007LOTRELAMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDECAPSULE;ORALEQ 5MG BASE;40MGYesNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 6 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020364-002LOTRELAMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDEEQ 2.5MG BASE;10MGCAPSULE / ORALRLD1995-03-03
N020364-003LOTRELAMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDEEQ 5MG BASE;10MGCAPSULE / ORALRLD1995-03-03
N020364-004LOTRELAMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDEEQ 5MG BASE;20MGCAPSULE / ORALRLD1995-03-03
N020364-005LOTRELAMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDEEQ 10MG BASE;20MGCAPSULE / ORALRLD2002-06-20
N020364-006LOTRELAMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDEEQ 10MG BASE;40MGCAPSULE / ORALRLD2006-04-11
N020364-007LOTRELAMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDEEQ 5MG BASE;40MGCAPSULE / ORALRLD2006-04-11

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 7 · 258 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N020364-002LOTRELEQ 2.5MG BASE;10MGCAPSULE / ORALRLD1995-03-0384e616aacf4f…
2026-09-14 22:38:342026-08N020364-003LOTRELEQ 5MG BASE;10MGCAPSULE / ORALRLD1995-03-0384e616aacf4f…
2026-09-14 22:38:342026-08N020364-004LOTRELEQ 5MG BASE;20MGCAPSULE / ORALRLD1995-03-0384e616aacf4f…
2026-09-14 22:38:342026-08N020364-005LOTRELEQ 10MG BASE;20MGCAPSULE / ORALRLD2002-06-2084e616aacf4f…
2026-09-14 22:38:342026-08N020364-006LOTRELEQ 10MG BASE;40MGCAPSULE / ORALRLD2006-04-1184e616aacf4f…
2026-09-14 22:38:342026-08N020364-007LOTRELEQ 5MG BASE;40MGCAPSULE / ORALRLD2006-04-1184e616aacf4f…
2026-08-18 06:07:402026-07N020364-002LOTRELEQ 2.5MG BASE;10MGCAPSULE / ORALRLD1995-03-03caaa826d4ba7…
2026-08-18 06:07:402026-07N020364-003LOTRELEQ 5MG BASE;10MGCAPSULE / ORALRLD1995-03-03caaa826d4ba7…
2026-08-18 06:07:402026-07N020364-004LOTRELEQ 5MG BASE;20MGCAPSULE / ORALRLD1995-03-03caaa826d4ba7…
2026-08-18 06:07:402026-07N020364-005LOTRELEQ 10MG BASE;20MGCAPSULE / ORALRLD2002-06-20caaa826d4ba7…
2026-08-18 06:07:402026-07N020364-006LOTRELEQ 10MG BASE;40MGCAPSULE / ORALRLD2006-04-11caaa826d4ba7…
2026-08-18 06:07:402026-07N020364-007LOTRELEQ 5MG BASE;40MGCAPSULE / ORALRLD2006-04-11caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N020364-002LOTRELEQ 2.5MG BASE;10MGCAPSULE / ORALABRLD1995-03-03011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020364-003LOTRELEQ 5MG BASE;10MGCAPSULE / ORALABRLD1995-03-03011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020364-004LOTRELEQ 5MG BASE;20MGCAPSULE / ORALABRLD1995-03-03011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020364-005LOTRELEQ 10MG BASE;20MGCAPSULE / ORALABRLD2002-06-20011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020364-006LOTRELEQ 10MG BASE;40MGCAPSULE / ORALABRLD, RS2006-04-11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020364-007LOTRELEQ 5MG BASE;40MGCAPSULE / ORALABRLD2006-04-11011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020364-002LOTRELEQ 2.5MG BASE;10MGCAPSULE / ORALABRLD1995-03-0331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020364-003LOTRELEQ 5MG BASE;10MGCAPSULE / ORALABRLD1995-03-0331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020364-004LOTRELEQ 5MG BASE;20MGCAPSULE / ORALABRLD1995-03-0331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020364-005LOTRELEQ 10MG BASE;20MGCAPSULE / ORALABRLD2002-06-2031067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020364-006LOTRELEQ 10MG BASE;40MGCAPSULE / ORALABRLD, RS2006-04-1131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020364-007LOTRELEQ 5MG BASE;40MGCAPSULE / ORALABRLD2006-04-1131067a03dcf5…
2025-08-23 18:47 UTC2025-08N020364-002LOTRELEQ 2.5MG BASE;10MGCAPSULE / ORALABRLD1995-03-036a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020364-003LOTRELEQ 5MG BASE;10MGCAPSULE / ORALABRLD1995-03-036a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020364-004LOTRELEQ 5MG BASE;20MGCAPSULE / ORALABRLD1995-03-036a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020364-005LOTRELEQ 10MG BASE;20MGCAPSULE / ORALABRLD2002-06-206a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020364-006LOTRELEQ 10MG BASE;40MGCAPSULE / ORALABRLD, RS2006-04-116a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020364-007LOTRELEQ 5MG BASE;40MGCAPSULE / ORALABRLD2006-04-116a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020364-002LOTRELEQ 2.5MG BASE;10MGCAPSULE / ORALABRLD1995-03-03fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020364-003LOTRELEQ 5MG BASE;10MGCAPSULE / ORALABRLD1995-03-03fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020364-004LOTRELEQ 5MG BASE;20MGCAPSULE / ORALABRLD1995-03-03fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020364-005LOTRELEQ 10MG BASE;20MGCAPSULE / ORALABRLD2002-06-20fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020364-006LOTRELEQ 10MG BASE;40MGCAPSULE / ORALABRLD, RS2006-04-11fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020364-007LOTRELEQ 5MG BASE;40MGCAPSULE / ORALABRLD2006-04-11fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020364-002LOTRELEQ 2.5MG BASE;10MGCAPSULE / ORALABRLD1995-03-03b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020364-003LOTRELEQ 5MG BASE;10MGCAPSULE / ORALABRLD1995-03-03b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020364-004LOTRELEQ 5MG BASE;20MGCAPSULE / ORALABRLD1995-03-03b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020364-005LOTRELEQ 10MG BASE;20MGCAPSULE / ORALABRLD2002-06-20b8a1b40f171c…

Observed Orange Book normalized TE history#

Normalized TE history page 3 of 6 · 240 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2024-05-31 18:47 UTC2024-05N020364-004AB18072bd15b7f6…
2024-05-31 18:47 UTC2024-05N020364-005AB18072bd15b7f6…
2024-05-31 18:47 UTC2024-05N020364-006AB18072bd15b7f6…
2024-05-31 18:47 UTC2024-05N020364-007AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020364-002AB15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020364-003AB15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020364-004AB15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020364-005AB15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020364-006AB15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020364-007AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N020364-002AB15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N020364-003AB15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N020364-004AB15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N020364-005AB15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N020364-006AB15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N020364-007AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N020364-002AB14b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N020364-003AB14b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N020364-004AB14b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N020364-005AB14b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N020364-006AB14b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N020364-007AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N020364-002AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12N020364-003AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12N020364-004AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12N020364-005AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12N020364-006AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12N020364-007AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03N020364-002AB1bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03N020364-003AB1bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03N020364-004AB1bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03N020364-005AB1bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03N020364-006AB1bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03N020364-007AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N020364-002AB1782e0a99824c…
2021-12-28 21:50 UTC2021-12N020364-003AB1782e0a99824c…
2021-12-28 21:50 UTC2021-12N020364-004AB1782e0a99824c…
2021-12-28 21:50 UTC2021-12N020364-005AB1782e0a99824c…
2021-12-28 21:50 UTC2021-12N020364-006AB1782e0a99824c…
2021-12-28 21:50 UTC2021-12N020364-007AB1782e0a99824c…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 56 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0078-0364Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0364Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0364Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0364Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0364Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0364Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0364Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0379Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0379Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0379Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0379Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0379Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0379Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0379Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0384Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0404Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0405Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0405Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0405Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0405Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0405Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0405Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0405Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0406Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0406Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0406Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0406Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0406Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0406Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0078-0406Lotrelamlodipine besylate and benazepril hydrochlorideNovartis Pharmaceuticals CorporationNDACurrent
0615-1397amlodipine besylate and benazepril hydrochlorideamlodipine besylate and benazepril hydrochlorideNCS HealthCare of KY, Inc dba Vangard LabsNDACurrent
0615-1398amlodipine besylate and benazepril hydrochlorideamlodipine besylate and benazepril hydrochlorideNCS HealthCare of KY, Inc dba Vangard LabsNDACurrent
0615-1399amlodipine besylate and benazepril hydrochlorideamlodipine besylate and benazepril hydrochlorideNCS HealthCare of KY, Inc dba Vangard LabsNDACurrent
0781-2271Amlodipine Besylate and Benazepril Hydrochlorideamlodipine besylate and benazepril hydrochlorideSandoz IncNDA AUTHORIZED GENERICCurrent
0781-2272Amlodipine Besylate and Benazepril Hydrochlorideamlodipine besylate and benazepril hydrochlorideSandoz IncNDA AUTHORIZED GENERICCurrent
0781-2273Amlodipine Besylate and Benazepril Hydrochlorideamlodipine besylate and benazepril hydrochlorideSandoz IncNDA AUTHORIZED GENERICCurrent
0781-2274Amlodipine Besylate and Benazepril Hydrochlorideamlodipine besylate and benazepril hydrochlorideSandoz IncNDA AUTHORIZED GENERICCurrent
0781-2277Amlodipine Besylate and Benazepril Hydrochlorideamlodipine besylate and benazepril hydrochlorideSandoz IncNDA AUTHORIZED GENERICCurrent
0781-2279Amlodipine Besylate and Benazepril Hydrochlorideamlodipine besylate and benazepril hydrochlorideSandoz IncNDA AUTHORIZED GENERICCurrent
43063-233Amlodipine Besylate and Benazepril Hydrochlorideamlodipine besylate and benazepril hydrochloridePD-Rx Pharmaceuticals, Inc.NDACurrent
55289-039Lotrelamlodipine besylate and benazepril hydrochloridePD-Rx Pharmaceuticals, Inc.NDACurrent
55289-039Lotrelamlodipine besylate and benazepril hydrochloridePD-Rx Pharmaceuticals, Inc.NDACurrent
55289-039Lotrelamlodipine besylate and benazepril hydrochloridePD-Rx Pharmaceuticals, Inc.NDACurrent
55289-039Lotrelamlodipine besylate and benazepril hydrochloridePD-Rx Pharmaceuticals, Inc.NDACurrent
55289-039Lotrelamlodipine besylate and benazepril hydrochloridePD-Rx Pharmaceuticals, Inc.NDACurrent
55289-039Lotrelamlodipine besylate and benazepril hydrochloridePD-Rx Pharmaceuticals, Inc.NDACurrent
55289-039Lotrelamlodipine besylate and benazepril hydrochloridePD-Rx Pharmaceuticals, Inc.NDACurrent
55289-096Lotrelamlodipine besylate and benazepril hydrochloridePD-Rx Pharmaceuticals, Inc.NDACurrent
55289-096Lotrelamlodipine besylate and benazepril hydrochloridePD-Rx Pharmaceuticals, Inc.NDACurrent
55289-096Lotrelamlodipine besylate and benazepril hydrochloridePD-Rx Pharmaceuticals, Inc.NDACurrent
55289-096Lotrelamlodipine besylate and benazepril hydrochloridePD-Rx Pharmaceuticals, Inc.NDACurrent
55289-096Lotrelamlodipine besylate and benazepril hydrochloridePD-Rx Pharmaceuticals, Inc.NDACurrent
55289-096Lotrelamlodipine besylate and benazepril hydrochloridePD-Rx Pharmaceuticals, Inc.NDACurrent
55289-096Lotrelamlodipine besylate and benazepril hydrochloridePD-Rx Pharmaceuticals, Inc.NDACurrent
68151-1363Amlodipine Besylate and Benazepril Hydrochlorideamlodipine besylate and benazepril hydrochlorideCarilion Materials ManagementNDA AUTHORIZED GENERICCurrent
68151-1365Amlodipine Besylate and Benazepril Hydrochlorideamlodipine besylate and benazepril hydrochlorideCarilion Materials ManagementNDA AUTHORIZED GENERICCurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
67881SUPPL2021-06-24
67138SUPPL2021-04-22
61861SUPPL2020-02-11
61859SUPPL2020-02-11
49072SUPPL2017-07-25
49050SUPPL2017-07-25
34560SUPPL2015-05-21
24854SUPPL2015-05-19
12490SUPPL2015-04-24
24853SUPPL2015-04-23
34559SUPPL2015-01-05
24852SUPPL2014-12-30
24851SUPPL2012-10-10
2396SUPPL2012-10-10
34558SUPPL2012-10-09
12489SUPPL2012-10-09
34557SUPPL2012-01-23
24850SUPPL2012-01-23
12488SUPPL2011-11-01
2395SUPPL2011-10-31
34556SUPPL2011-07-07
24849SUPPL2011-06-29
24848SUPPL2011-01-07
12487SUPPL2011-01-05
34554SUPPL2010-04-04
24847SUPPL2010-04-02
2394SUPPL2010-01-05
34555SUPPL2010-01-04
24846SUPPL2009-11-19
12486SUPPL2009-10-30
24845SUPPL2007-09-06
12485SUPPL2007-09-04
2393SUPPL2007-03-06
24843SUPPL2006-04-13
12483SUPPL2006-04-12
2392SUPPL2004-08-12
12484SUPPL2004-07-07
24844SUPPL2004-07-06
2391SUPPL2003-09-09
20611SUPPL2002-11-22
24842SUPPL2002-06-20
12482SUPPL2002-06-20
41302SUPPL2001-08-21
34553SUPPL1999-06-16
24841SUPPL1999-06-16
41301SUPPL1997-03-14